Newsroom
Sorted by: Latest
-
Genspark Unveils AI Workspace 6.0: Betting AI’s Next Breakthrough Isn’t Models, It’s Context
PALO ALTO, Calif.--(BUSINESS WIRE)--Genspark.ai today launched Genspark AI Workspace 6.0, its most ambitious release to date. First previewed at the New York Stock Exchange, Genspark AI Workspace 6.0 moves the category beyond one-off content generation toward a system where work does itself. It is powered by a new persistent memory foundation, an enhanced agent suite, and a collaboration layer that treats AI agents as full teammates. "Today, using AI is like collaborating with a genius who has...
-
Samenvatting: Europese Commissie keurt Crysvita® (burosumab) goed voor zuigelingen met X-gebonden hypofosfatemie in de Europese Unie
GALASHIELS, Schotland & MARLOW, Engeland--(BUSINESS WIRE)--Kyowa Kirin EMEA, een volledige dochteronderneming van Kyowa Kirin Co., Ltd. (TSE:4151), heeft vandaag bekendgemaakt dat de Europese Commissie (EC) een uitbreiding van de indicatie voor Crysvita® (burosumab) voor de behandeling van X-gebonden hypofosfatemie (XLH) heeft goedgekeurd. Zuigelingen van 1 maand tot 1 jaar in de hele Europese Unie en de Europese Economische Ruimte kunnen deze behandeling nu ook krijgen. Deze bekendmaking is of...
-
Riassunto: La Commissione europea autorizza l'uso di Crysvita® (burosumab) per i neonati affetti da ipofosfatemia legata al cromosoma X nell'Unione europea
GALASHIELS, Scozia e MARLOW, Inghilterra--(BUSINESS WIRE)--Kyowa Kirin EMEA, una controllata al 100% di Kyowa Kirin Co., Ltd. (TSE:4151), ha annunciato oggi che la Commissione europea ha autorizzato un’estensione dell'indicazione terapeutica di Crysvita® (burosumab) per il trattamento dell’ipofosfatemia legata al cromosoma X (XLH), al fine di includere i neonati di età compresa tra 1 mese e 1 anno, in tutta l’Unione europea e nello Spazio economico europeo. Il testo originale del presente annun...
-
Resumen: La Comisión Europea aprueba Crysvita® (burosumab) para lactantes con hipofosfatemia ligada al cromosoma X en la Unión Europea
GALASHIELS, Escocia, y MARLOW, Inglaterra--(BUSINESS WIRE)--Kyowa Kirin EMEA, una filial al 100 % de Kyowa Kirin Co., Ltd. (TSE:4151), ha anunciado hoy que la Comisión Europea (CE) ha aprobado la ampliación de la indicación de Crysvita® (burosumab) para el tratamiento de la hipofosfatemia ligada al cromosoma X (XLH), de modo que incluya a los lactantes de entre 1 mes y 1 año de edad en toda la Unión Europea y el Espacio Económico Europeo. El comunicado en el idioma original es la versión oficia...
-
Forum Real Estate Income Fund (Ticker: FORAX) Surpasses $500 Million in Net Assets
DENVER--(BUSINESS WIRE)--Forum Investment Group today announced that its Forum Real Estate Income Fund ("FREIF" or "the Fund," Ticker: FORAX) has surpassed $500 million in net assets under management (AUM) as of July 7, 2026 — growth of approximately 73% over the trailing twelve months, more than doubling the Fund’s net AUM over the past 18 months. FORAX seeks high income with low volatility and an emphasis on capital preservation, investing across private real estate credit and public real est...
-
Summer at South Coast Plaza Brings Seven New Restaurants, Broadway Blockbusters and Seasonal Fun for All Ages
COSTA MESA, Calif.--(BUSINESS WIRE)--South Coast Plaza, Southern California's premier luxury shopping, dining and cultural destination, offers an unrivaled way to spend a summer day. From acclaimed new restaurants and anticipated dining destinations to Broadway productions next door at Segerstrom Center for the Arts, guests have a reason to stay from morning coffee to the final curtain, with plenty of family-friendly experiences rounding out the season through early fall. Seven new dining conce...
-
Keysight Addresses Cross-Domain Physics Issues That Leave Electronic Designs Vulnerable to Late-Stage Failure
SANTA ROSA, Calif.--(BUSINESS WIRE)--Solution built to streamline design complexity launches its first application targeting structural analysis....
-
City of Hope Opens National Lung Cancer Clinical Trial Seeking to Predict Immunotherapy Success
LOS ANGELES--(BUSINESS WIRE)--City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, has opened an innovative Phase 2 clinical trial designed to map how tumors change as they begin to resist immunotherapy, treatment that improves the immune system’s ability to fight disease. The research will focus on advanced non-small cell...
-
Box Unveils New Controls to Secure AI Agents Operating Across Enterprise Content
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Box, Inc. (NYSE: BOX), the leading Intelligent Content Management (ICM) platform, today announced new security capabilities designed to give organizations greater control over AI agents working with enterprise content. With new agent guardrails, third-party agent activity oversight, prompt injection detection, agent classification-based access policies, and more, customers will be able to extend Box’s enterprise-grade security controls to both Box Agents a...
-
More Than 400 Middle Tennessee Children Receive Free Dental Care, New Shoes and Back-to-School Resources at Kids Dental Day
NASHVILLE, Tenn.--(BUSINESS WIRE)--More than 400 children received free dental care, oral health education, new shoes, books, and more during the fifth annual Kids Dental Day....